The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator

Thomas E Pennington; John F Thompson; Robyn P M Saw; David J Coker; Serigne N Lo; Alex H R Varey

doi:10.1245/s10434-024-16699-3

The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator

Ann Surg Oncol. 2025 Aug;32(8):5382-5386. doi: 10.1245/s10434-024-16699-3. Epub 2025 May 2.

Authors

Thomas E Pennington^{1

2

3}, John F Thompson^{4

5

6}, Robyn P M Saw^{4

5

6}, David J Coker^{4

5

6}, Serigne N Lo^{4

5}, Alex H R Varey^{4

5

7}

Affiliations

¹ Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia. pennington_tom@hotmail.com.
² Melanoma Institute Australia, Wollstonecraft, Australia. pennington_tom@hotmail.com.
³ Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, Australia. pennington_tom@hotmail.com.
⁴ Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
⁵ Melanoma Institute Australia, Wollstonecraft, Australia.
⁶ Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, Australia.
⁷ Department of Plastic and Reconstructive Surgery, Westmead Hospital, Westmead, Australia.

No abstract available